[go: up one dir, main page]

TR200901109T1 - Tüberkülozun teşhisi ve immünoterapi yolu ile önlenmesine mahsus yöntemler ve bileşikler - Google Patents

Tüberkülozun teşhisi ve immünoterapi yolu ile önlenmesine mahsus yöntemler ve bileşikler

Info

Publication number
TR200901109T1
TR200901109T1 TR2009/01109T TR200901109T TR200901109T1 TR 200901109 T1 TR200901109 T1 TR 200901109T1 TR 2009/01109 T TR2009/01109 T TR 2009/01109T TR 200901109 T TR200901109 T TR 200901109T TR 200901109 T1 TR200901109 T1 TR 200901109T1
Authority
TR
Turkey
Prior art keywords
tuberculosis
compounds
diagnosis
methods
prevention
Prior art date
Application number
TR2009/01109T
Other languages
English (en)
Inventor
G. Reed Steven
A. W. Skeiky Yasir
C. Dillon Davin
Campos-Neto Antonio
Houghton Raymond
H. Vedvick Thomas
R. Twardzik Daniel
Original Assignee
Corixa Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27541835&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR200901109(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Corixa Corporation filed Critical Corixa Corporation
Publication of TR200901109T1 publication Critical patent/TR200901109T1/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Cell Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Tüberkülozun teşhisi ve immünoterapi yolu ile önlenmesine mahsus yöntemler ve bileşikler Tüberküloza karşı koruyucu bağışıklık sağlayan bileşikler ve yöntemler açıklanmaktadır. Sağlanan bileşikler bir ya da daha fazla M. tuberculosis proteininin en az bir immünojenik kısmını içeren polipeptidleri ve böyle polipeptidleri kodlayan DNA moleküllerini ihtiva etmektedir. Böyle bileşikler M. tuberculosis enfeksiyonuna karşı bağışıklık sağlayan aşılar ve/veya farmasötik kompozisyonlar halinde formüle edilebilmekte ve tüberkülozun teşhisi için kullanılabilmektedir.
TR2009/01109T 1995-09-01 1996-08-30 Tüberkülozun teşhisi ve immünoterapi yolu ile önlenmesine mahsus yöntemler ve bileşikler TR200901109T1 (tr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US52343695A 1995-09-01 1995-09-01
US53363495A 1995-09-22 1995-09-22
US62087496A 1996-03-22 1996-03-22
US65968396A 1996-06-05 1996-06-05
US68057496A 1996-07-12 1996-07-12

Publications (1)

Publication Number Publication Date
TR200901109T1 true TR200901109T1 (tr) 2012-02-21

Family

ID=27541835

Family Applications (5)

Application Number Title Priority Date Filing Date
TR2008/06258T TR200806258T2 (tr) 1995-09-01 1996-08-30 Tüberkülozun teşhisi ve immünoterapi yolu ile önlenmesine mahsus yöntemler ve bileşikler
TR2008/06259T TR200806259T2 (tr) 1995-09-01 1996-08-30 Tüberkülozun teşhisi ve immünoterapi yolu ile önlenmesine mahsus yöntemler ve bileşikler
TR2009/01109T TR200901109T1 (tr) 1995-09-01 1996-08-30 Tüberkülozun teşhisi ve immünoterapi yolu ile önlenmesine mahsus yöntemler ve bileşikler
TR2004/03064T TR200403064T2 (tr) 1995-09-01 1996-08-30 Tüberkülozun teşhisi ve immünoterapi yolu ile önlenmesine mahsus yöntemler ve bileşikler.
TR1998/00411T TR199800411T1 (tr) 1995-09-01 1996-08-30 Tüberkülozun teshisi ve immünoterapi yolu ile önlenmesine mahsus yöntemler ve bilesikler.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
TR2008/06258T TR200806258T2 (tr) 1995-09-01 1996-08-30 Tüberkülozun teşhisi ve immünoterapi yolu ile önlenmesine mahsus yöntemler ve bileşikler
TR2008/06259T TR200806259T2 (tr) 1995-09-01 1996-08-30 Tüberkülozun teşhisi ve immünoterapi yolu ile önlenmesine mahsus yöntemler ve bileşikler

Family Applications After (2)

Application Number Title Priority Date Filing Date
TR2004/03064T TR200403064T2 (tr) 1995-09-01 1996-08-30 Tüberkülozun teşhisi ve immünoterapi yolu ile önlenmesine mahsus yöntemler ve bileşikler.
TR1998/00411T TR199800411T1 (tr) 1995-09-01 1996-08-30 Tüberkülozun teshisi ve immünoterapi yolu ile önlenmesine mahsus yöntemler ve bilesikler.

Country Status (23)

Country Link
EP (5) EP1712628B1 (tr)
JP (5) JP4382160B2 (tr)
KR (1) KR100433750B1 (tr)
CN (1) CN1117149C (tr)
AT (5) ATE426025T1 (tr)
AU (1) AU727602B2 (tr)
BR (2) BR9610262B1 (tr)
CA (3) CA2684425A1 (tr)
CY (2) CY2570B1 (tr)
CZ (3) CZ300688B6 (tr)
DE (4) DE69637879D1 (tr)
DK (4) DK0851927T3 (tr)
ES (4) ES2324529T3 (tr)
HU (2) HU225979B1 (tr)
IL (1) IL123506A (tr)
MX (1) MX9801638A (tr)
NO (4) NO324372B1 (tr)
NZ (1) NZ319377A (tr)
PL (1) PL186774B1 (tr)
PT (4) PT1398379E (tr)
SI (1) SI0851927T1 (tr)
TR (5) TR200806258T2 (tr)
WO (1) WO1997009428A2 (tr)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2501135Y2 (ja) 1989-06-10 1996-06-12 エヌティエヌ株式会社 摩擦式無段変速機
JP2501911B2 (ja) 1989-08-15 1996-05-29 日産自動車株式会社 トロイダル型無段変速機
US6641814B1 (en) 1997-04-02 2003-11-04 Statens Serum Institut Nucleic acids fragments and polypeptide fragments derived from M. tuberculosis
US6991797B2 (en) 1993-07-02 2006-01-31 Statens Serum Institut M. tuberculosis antigens
US6290969B1 (en) * 1995-09-01 2001-09-18 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
US6458366B1 (en) 1995-09-01 2002-10-01 Corixa Corporation Compounds and methods for diagnosis of tuberculosis
US6592877B1 (en) 1995-09-01 2003-07-15 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
PL333304A1 (en) * 1996-10-11 1999-11-22 Corixa Corp Techniques and methods of tuberculosis diagnosis
US6544522B1 (en) * 1998-12-30 2003-04-08 Corixa Corporation Fusion proteins of mycobacterium tuberculosis antigens and their uses
US6350456B1 (en) 1997-03-13 2002-02-26 Corixa Corporation Compositions and methods for the prevention and treatment of M. tuberculosis infection
US6627198B2 (en) 1997-03-13 2003-09-30 Corixa Corporation Fusion proteins of Mycobacterium tuberculosis antigens and their uses
US6982085B2 (en) 1997-04-02 2006-01-03 Statens Serum Institut TB diagnostic based on antigens from M. tuberculosis
DE69838268T2 (de) * 1997-04-02 2008-05-08 Statens Serum Institut Immonologisch aktiven, neuen Polypeptidefragmenten
US7037510B2 (en) 1997-04-18 2006-05-02 Statens Serum Institut Hybrids of M. tuberculosis antigens
US6555653B2 (en) 1997-05-20 2003-04-29 Corixa Corporation Compounds for diagnosis of tuberculosis and methods for their use
US6613881B1 (en) * 1997-05-20 2003-09-02 Corixa Corporation Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use
CA2296419A1 (en) * 1997-07-16 1999-01-28 Institut Pasteur A polynucleotide functionally coding for the lhp protein from mycobacterium tuberculosis, its biologically active derivative fragments, as well as methods using the same
EP1484405A1 (en) * 1997-11-10 2004-12-08 Statens Serum Institut Nucleic acid fragments and polypeptide fragments derived from M. Tuberculosis
WO1999024577A1 (en) * 1997-11-10 1999-05-20 Statens Serum Institut NUCLEIC ACID FRAGMENTS AND POLYPEPTIDE FRAGMENTS DERIVED FROM $i(M. TUBERCULOSIS)
IL138809A0 (en) * 1998-04-07 2001-10-31 Corixa Corp Fusion proteins of mycobacterium tuberculosis antigens and pharmaceutical compositions containing the same
GB9808720D0 (en) * 1998-04-23 1998-06-24 Smithkline Beecham Biolog Novel compounds
AU6480999A (en) * 1998-11-04 2000-05-22 Isis Innovation Limited Tuberculosis diagnostic test
US6465633B1 (en) 1998-12-24 2002-10-15 Corixa Corporation Compositions and methods of their use in the treatment, prevention and diagnosis of tuberculosis
AU2594500A (en) * 1998-12-24 2000-07-31 Corixa Corporation Methods for using mycobacterium tuberculosis molecules as immunological adjuvants
US7932373B1 (en) 1999-05-04 2011-04-26 University Of Medicine And Dentistry Of New Jersey Proteins expressed by mycobacterium tuberculosis and not by BCG and their use as diagnostic reagents and vaccines
US7009042B1 (en) * 1999-10-07 2006-03-07 Corixa Corporation Methods of using a Mycobacterium tuberculosis coding sequence to facilitate stable and high yield expression of the heterologous proteins
US6316205B1 (en) 2000-01-28 2001-11-13 Genelabs Diagnostics Pte Ltd. Assay devices and methods of analyte detection
AU2001241738A1 (en) 2000-02-25 2001-09-03 Corixa Corporation Compounds and methods for diagnosis and immunotherapy of tuberculosis
DK2133100T3 (da) 2000-06-20 2012-01-23 Corixa Corp MTB32A-Antigen af Mycobacterium tuberculosis med inaktiveret aktivt sted og fusionsproteiner deraf
WO2003070187A2 (en) 2002-02-15 2003-08-28 Corixa Corporation Fusion proteins of mycobacterium tuberculosis
ITRM20040091A1 (it) 2004-02-19 2004-05-19 Istituto Naz Per Le Malattie Test immunologico rapido per la diagnosi ed il monitoraggio dell'infezione tubercolare.
FI119445B (fi) * 2004-10-29 2008-11-14 Waertsilae Finland Oy Polttomoottorin polttoaineen syöttöjärjestelmän paineen värähtelyn vaimennin
CN101090974B (zh) 2004-11-16 2011-05-11 克鲁塞尔荷兰公司 包含重组病毒载体的多价疫苗
KR20120089475A (ko) 2005-04-29 2012-08-10 인펙셔스 디지즈 리서치 인스티튜트 (아이디알아이) 결핵균 감염을 예방 또는 치료하기 위한 신규한 방법
FR2952058B1 (fr) 2009-10-29 2013-10-04 Centre Nat Rech Scient Procede de ligation native de polypeptides
LT2528621T (lt) 2010-01-27 2016-12-12 Glaxosmithkline Biologicals S.A. Modifikuoti tuberkuliozės antigenai
KR20190022897A (ko) 2010-12-14 2019-03-06 글락소스미스클라인 바이오로지칼즈 에스.에이. 미코박테리움 항원성 조성물
FR2971509B1 (fr) * 2011-02-16 2013-02-22 Centre Nat Rech Scient Procede de preparation de peptides par assemblage de multiples fragments peptidiques
CN103290030A (zh) * 2012-02-23 2013-09-11 上海交通大学 一种结核分枝杆菌标志物HtdY的重组蛋白及其制备方法和临床应用
KR102125658B1 (ko) * 2012-05-04 2020-06-22 화이자 인코포레이티드 전립선 관련된 항원 및 백신 기재 면역치료 요법
EP3125694A1 (en) * 2014-04-04 2017-02-08 Vestaron Corporation Artificially activated toxic peptides
GB201513176D0 (en) 2015-07-27 2015-09-09 Glaxosmithkline Biolog Sa Novel methods for inducing an immune response
FR3048286B1 (fr) * 2016-02-26 2021-01-22 Omunis Peptides immunogenes et leur utilisation
CN107304231B (zh) * 2016-04-18 2021-01-01 华中农业大学 一种结核分枝杆菌融合蛋白及应用
GB201614485D0 (en) * 2016-08-25 2016-10-12 Univ Oxford Innovation Ltd Immunogenic composition

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2244539A1 (en) * 1973-07-13 1975-04-18 Mitsui Pharmaceuticals Tuberculin active proteins and peptides prepn - from tubercle bacillus
FR2265402A1 (en) * 1974-03-29 1975-10-24 Mitsui Pharmaceuticals Tuberculin active proteins and peptides prepn - from tubercle bacillus
US4876089A (en) * 1984-09-06 1989-10-24 Chiron Corporation Feline leukemia virus protein vaccines
US4751180A (en) 1985-03-28 1988-06-14 Chiron Corporation Expression using fused genes providing for protein product
US4935233A (en) 1985-12-02 1990-06-19 G. D. Searle And Company Covalently linked polypeptide cell modulators
US5075109A (en) 1986-10-24 1991-12-24 Southern Research Institute Method of potentiating an immune response
US4897268A (en) 1987-08-03 1990-01-30 Southern Research Institute Drug delivery system and method of making the same
FR2677365B1 (fr) * 1991-06-07 1995-08-04 Pasteur Institut Proteines de mycobacterium et applications.
US5330754A (en) * 1992-06-29 1994-07-19 Archana Kapoor Membrane-associated immunogens of mycobacteria
DK79893D0 (da) * 1993-07-02 1993-07-02 Statens Seruminstitut New vaccine
DK79793D0 (da) * 1993-07-02 1993-07-02 Statens Seruminstitut Diagnostic test

Also Published As

Publication number Publication date
HU227778B1 (en) 2012-02-28
KR100433750B1 (ko) 2004-09-01
DE69637879D1 (de) 2009-04-30
EP1203817B1 (en) 2006-04-12
NO20070619L (no) 1998-04-27
EP1398379B1 (en) 2006-08-23
CZ62898A3 (cs) 1999-10-13
CZ297406B6 (cs) 2006-12-13
EP1712628A3 (en) 2007-05-23
ATE426025T1 (de) 2009-04-15
HU225979B1 (en) 2008-02-28
WO1997009428A2 (en) 1997-03-13
PL186774B1 (pl) 2004-02-27
PT851927E (pt) 2004-03-31
JP2001517069A (ja) 2001-10-02
IL123506A0 (en) 1998-10-30
CN1117149C (zh) 2003-08-06
ES2271449T3 (es) 2007-04-16
WO1997009428A3 (en) 1997-07-17
TR199800411T1 (tr) 1998-05-21
EP1347055B1 (en) 2009-03-18
TR200403064T2 (tr) 2005-08-22
HUP9900902A2 (hu) 1999-07-28
NO20070618L (no) 1998-04-27
NZ319377A (en) 2000-01-28
JP4324597B2 (ja) 2009-09-02
JP2007228972A (ja) 2007-09-13
EP1712628A2 (en) 2006-10-18
CA2653566A1 (en) 1997-03-13
DE69630457D1 (de) 2003-11-27
KR19990044347A (ko) 1999-06-25
BR9610262A (pt) 1999-07-06
ATE513915T1 (de) 2011-07-15
ES2210392T3 (es) 2004-07-01
PL325373A1 (en) 1998-07-20
ATE323165T1 (de) 2006-04-15
ATE337399T1 (de) 2006-09-15
BR9612997B1 (pt) 2012-01-10
JP4324618B2 (ja) 2009-09-02
NO336288B1 (no) 2015-07-13
NO980883D0 (no) 1998-02-27
CA2653566C (en) 2013-06-25
CN1200147A (zh) 1998-11-25
DE69636046D1 (de) 2006-05-24
JP4382160B2 (ja) 2009-12-09
ES2262595T3 (es) 2006-12-01
BR9610262B1 (pt) 2013-11-26
TR200806259T2 (tr) 2008-10-21
IL123506A (en) 2004-12-15
EP1347055A3 (en) 2003-11-26
EP0851927B1 (en) 2003-10-22
DE69636487D1 (de) 2006-10-05
CA2684425A1 (en) 1997-03-13
ATE252640T1 (de) 2003-11-15
EP1398379A2 (en) 2004-03-17
DK1203817T3 (da) 2006-08-14
EP1203817A3 (en) 2003-01-29
CA2230885A1 (en) 1997-03-13
CZ300953B6 (cs) 2009-09-23
MX9801638A (es) 1998-05-31
NO324372B1 (no) 2007-10-01
PT1347055E (pt) 2009-06-19
TR200806258T2 (tr) 2008-10-21
JP2006149406A (ja) 2006-06-15
DE69636487T2 (de) 2007-05-03
EP1203817B9 (en) 2006-08-16
CY2570B1 (en) 2008-07-02
JP4324596B2 (ja) 2009-09-02
EP1712628B1 (en) 2011-06-22
DK1347055T3 (da) 2009-06-29
EP0851927A2 (en) 1998-07-08
NO980883L (no) 1998-04-27
CA2230885C (en) 2010-02-02
AU727602B2 (en) 2000-12-14
DE69636046T2 (de) 2006-11-23
DK0851927T3 (da) 2004-01-26
HUP9900902A3 (en) 2001-03-28
PT1398379E (pt) 2007-01-31
NO20070621L (no) 1998-04-27
EP1347055A2 (en) 2003-09-24
PT1203817E (pt) 2006-08-31
CZ300688B6 (cs) 2009-07-15
EP1203817A2 (en) 2002-05-08
ES2324529T3 (es) 2009-08-10
JP2006187292A (ja) 2006-07-20
AU7158696A (en) 1997-03-27
CY2612B2 (en) 2010-12-22
EP1398379A3 (en) 2004-07-14
SI0851927T1 (en) 2004-02-29
DK1398379T3 (da) 2007-01-08
HK1059282A1 (en) 2004-06-25
DE69630457T2 (de) 2004-11-25
JP2009159982A (ja) 2009-07-23

Similar Documents

Publication Publication Date Title
TR200901109T1 (tr) Tüberkülozun teşhisi ve immünoterapi yolu ile önlenmesine mahsus yöntemler ve bileşikler
TR200000115T2 (tr) Tüberkülozun immünoterapi ve teşhisi için bileşikler ve bu bileşiklerin kullanımı için yöntemler.
WO1998016646A3 (en) Compounds and methods for immunotherapy and diagnosis of tuberculosis
EP1071451A4 (en) COMPOUNDS AND METHODS FOR IMMUNOTHERAPY AND DIAGNOSIS OF TUBERCULOSIS
TR199700999T1 (tr) Askomisinler.
CY1108864T1 (el) Ενωσεις για ανοσοθεραπεια και διαγνωση φυματιωσης και μεθοδοι χρησεις τους
AR010517A1 (es) Compuestos y metodos para la inmunoterapia y diagnostico de tuberculosis